Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Regeneron Pharmaceuticals, Inc. REGN

Healthcare  —  Biotechnology
788.04 (7.98) (1.00%) as of 25 Sep
Market cap
$81.3B
P/E
18.8×
S&P 500 Member Revenue Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Regeneron Pharmaceuticals, Inc. (REGN) Current ratio

Regeneron Pharmaceuticals, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 3.3×, down 0.8× from fiscal 2025 (4.1×). Over the past ten years it has ranged from 2.6× (fiscal 2016) to 5.7× (fiscal 2023); the current reading is higher than 64% of that period. That is below the Biotechnology industry median of 4.7× and above the Healthcare sector median of 3.0×.

Current ratio, annual

Annual

Period Current ratio Change
FY2025 4.1× (12.80%)
FY2024 4.7× (16.85%)
FY2023 5.7× 12.53%
FY2022 5.1× 41.88%
FY2021 3.6× (1.70%)
FY2020 3.6× (1.15%)
FY2019 3.7× (17.93%)
FY2018 4.5× 17.05%
FY2017 3.8× 49.04%
FY2016 2.6× (28.72%)

Quarterly

Period Current ratio Change
Jun 2026 3.3× (6.44%)
Mar 2026 3.6× (13.59%)
Dec 2025 4.1× 1.53%
Sep 2025 4.1× (11.62%)
42 more quarters

Against its own ten years

Low 2.6× High 5.7×
Ten-year median 3.8×
Current reading's percentile 64

Current ratio against peers

Company Current ratio
RVMD Revolution Medicines, Inc. compare 11.4×
ARGX argenex SE compare 5.1×
INSM Insmed, Inc. compare 3.7×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 3.4×
REGN Regeneron Pharmaceuticals, Inc. 3.3×
VRTX Vertex Pharmaceuticals Incorporated compare 3.2×
ALNY Alnylam Pharmaceuticals, Inc. compare 3.1×
RPRX Royalty Pharma PLC compare 2.8×
MRNA Moderna, Inc. compare 2.3×
Biotechnology industry median 4.7×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on REGN